Today, medical researchers are developing mathematical ways to detect cancer more accurately.

Still, if the screen can stratify patients by the likelihood of their cancer coming back, they might be more comfortable deciding whether to begin chemotherapy.

The test measures the activity levels of various genes in the tumor and computes a score showing the risk of recurrence.